Cargando…
Efficacy and Safety of High Potent P2Y(12) Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex‐Specific Systematic Review and Meta‐Analysis
BACKGROUND: Sex differences in efficacy and safety of dual antiplatelet therapy remain uncertain because of the underrepresentation of women in cardiovascular trials. The aim of this study was to perform a sex‐specific analysis of the pooled efficacy and safety data of clinical trials comparing a hi...
Autores principales: | Schreuder, Michelle M., Badal, Ricardo, Boersma, Eric, Kavousi, Maryam, Roos‐Hesselink, Jolien, Versmissen, Jorie, Visser, Loes E., Roeters van Lennep, Jeanine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070195/ https://www.ncbi.nlm.nih.gov/pubmed/32063118 http://dx.doi.org/10.1161/JAHA.119.014457 |
Ejemplares similares
-
Cardiovascular Disease Risk Factor Burden During the Menopause Transition and Late Midlife Subclinical Vascular Disease: Does Race/Ethnicity Matter?
por: Barinas‐Mitchell, Emma, et al.
Publicado: (2020) -
Sex Differences Among Participants in the Latin American Stroke Registry
por: Arauz, Antonio, et al.
Publicado: (2020) -
Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
por: Bravo, Claudio A., et al.
Publicado: (2020) -
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study
por: Aldiwani, Haider, et al.
Publicado: (2020) -
Where are the Recommendations on Healthy Lifestyle and Cardiovascular Disease Prevention for Pregnant Women?
por: Banach, Maciej
Publicado: (2020)